Views & Analysis | Perspectives on pharma industry issues

Digital

pharmaphorum podcast Episode 284, Mati Gill, AION Labs

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

Articles

Healthcare markets in Asia: Indian medical device regulatory...

Ames Gross continues his overview of healthcare markets in Asia with an update on the medical device market in India. The medical device market in India was worth an estimated $3.2 billion in 2011, trailing only Japan, China and South Korea in Asia. The medical...

Articles

Emerging diagnostic technologies – the regulatory and reimbu...

Kyle Fetter offers advice on the current regulatory and reimbursement landscape surrounding emerging diagnostic technologies in our latest interview. The fastest growing segment of the laboratory market is molecular diagnostics. The rapid growth of molecular diagnostics as a segment of…

Articles

Tunnah’s musings: Skydiving pharma and the art of fall bette...

In the latest musings from our own Paul Tunnah, he wonders whether the patent cliff for pharma looks a little shallow compared to a 39km jump from space. Did you watch Felix Baumgartner jump out of that tiny capsule in the stratosphere at 128,000 feet as the first step on his way to breaking the sound barrier…

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

AI, start-ups, and the future of human health: AION Labs’ Ma...

In a new episode of the pharmaphorum podcast, Nicole Raleigh invites Mati Gill, CEO of AION Labs, back as guest.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.